RE: Phase 2a commencing this year is the official guidance from Sar29 Apr 2024 08:34
Brighty, thank you for your contributions to the board, especially in trying to put valuations on takeouts etc.
I, like many others, I'm sure would prefer a take out, lock stock and barrel. It removes the need to consider when to sell, something I am terrible at.
The only time I would prefer a licence is if we are offered enough $ up front for 1801 to enable a fast track like no other for 1802. However, I don't see John and Tim being able to fast track anything, apart from perhaps Priority boarding on an easyJet flight. Their way is slow and methodical. It serves a purpose, especially in getting clinical trials right. But a licence would only mean we have to wait 2 or 3+ years more for full value of all of our compounds...